關(guān)于新冠肺炎疫情致外國(guó)專家和國(guó)際友人的一封信

尊敬的外國(guó)專家和朋友：

  在新的一年里，新冠肺炎疫情牽動(dòng)了我國(guó)乃至世界各國(guó)人民的心。我謹(jǐn)向您對(duì)中國(guó)疫情防控工作的關(guān)注和支持表示誠(chéng)摯的感謝。

  疫情發(fā)生后，中國(guó)政府第一時(shí)間建立舉國(guó)體制，匯集全國(guó)資源，采取了最全面、最嚴(yán)格、最徹底的措施迎擊疫情，其中很多措施都超出了國(guó)際衛(wèi)生條例的要求和世界衛(wèi)生組織的建議。國(guó)家主席習(xí)近平多次作出重要指示，主持召開(kāi)會(huì)議，聽(tīng)取工作匯報(bào)，對(duì)疫情防控工作進(jìn)行研究、部署、動(dòng)員。

  全國(guó)采取聯(lián)防聯(lián)控機(jī)制，全力收治和保障危重病人的治療，對(duì)發(fā)現(xiàn)疑似病例和密切接觸者就地采取必要隔離措施和醫(yī)療支持。從各方面數(shù)據(jù)監(jiān)測(cè)和專家預(yù)測(cè)來(lái)看，當(dāng)前疫情正在逐步得到有效控制。

  中國(guó)廣大科技工作者正積極投身疫情防控和醫(yī)療救治的科研攻關(guān)工作中。政府科技部門積極組織科技攻關(guān)和服務(wù)，整合生物、健康、信息等領(lǐng)域的力量與資源，圍繞新型冠狀病毒重癥肺炎臨床救治關(guān)鍵技術(shù)研究、院感綜合防控技術(shù)研究、溯源與流行病學(xué)研究、致病機(jī)理研究、疫苗的開(kāi)發(fā)生產(chǎn)、藥物研發(fā)等方面，快速啟動(dòng)了防控新型冠狀病毒感染科技攻關(guān)相關(guān)應(yīng)急專項(xiàng)，目前在藥物臨床、快速試劑盒、病毒致病機(jī)理和傳播途徑等方面已取得了一些科研成果，為抗擊疫情提供了技術(shù)支撐。例如我所在的廣東省，致力于以中西醫(yī)結(jié)合和國(guó)際合作研發(fā)的方式開(kāi)發(fā)抗擊疫情新藥和老藥新用，初步遴選了一些有臨床效果的中藥和西藥；開(kāi)發(fā)了15分鐘快速診斷確認(rèn)試劑盒，已在實(shí)驗(yàn)室和臨床完成初步評(píng)價(jià)；開(kāi)發(fā)新型隔離床和隔離診臺(tái)在本地疫情定點(diǎn)醫(yī)院使用，有效提高院感防治水平；疫苗研發(fā)有望在近期取得階段性進(jìn)展，流行病溯源研究取得進(jìn)展。廣東省實(shí)驗(yàn)動(dòng)物監(jiān)測(cè)所已成功合成新型冠狀病毒N蛋白表達(dá)菌株，率先免費(fèi)開(kāi)放共享，縮短全國(guó)科研人員的研發(fā)時(shí)間，節(jié)約研發(fā)經(jīng)費(fèi)，引導(dǎo)樹(shù)立正確科研價(jià)值導(dǎo)向，到目前，已向中國(guó)及國(guó)際上的科研機(jī)構(gòu)、團(tuán)隊(duì)提供1090份。機(jī)器人、AI、大數(shù)據(jù)、無(wú)人機(jī)等技術(shù)也在疫情防控工作中被廣泛應(yīng)用，充分利用科技抗擊疫情。全省防控疫情依法科學(xué)有力有效，社會(huì)穩(wěn)定，各類生活必需品市場(chǎng)供應(yīng)充足，公共交通正常運(yùn)轉(zhuǎn)，醫(yī)療物資、生活物資、防疫工作運(yùn)輸暢通，正積極迎接返粵復(fù)工人流，扶持企業(yè)分類有序復(fù)工復(fù)產(chǎn)。同時(shí)，關(guān)于廣東我想告訴您的是，自2003年成功抗擊非典疫情之后，廣東大力加強(qiáng)傳染病防控科研能力建設(shè)，防控機(jī)制不斷完善，近年成功識(shí)別和阻斷H1N1、MERS等爆發(fā)在其他國(guó)家的流行病輸入和傳播，至今再未發(fā)生大規(guī)模傳染病。

  中國(guó)人民和政府對(duì)世界上其他國(guó)家爆發(fā)的疫病感同身受，積極提供人道主義援助，幫助疫病國(guó)家地區(qū)開(kāi)發(fā)疫苗和診斷治療方法。比如成功研制出甲型H1N1流感疫苗,與其他國(guó)家合作共同成功開(kāi)發(fā)了目前針對(duì)MERS病毒最好的治療藥物之一的全人源單克隆抗體(m336)，開(kāi)展資助包括科摩羅、巴布亞新幾內(nèi)亞等瘧疾流行國(guó)家全民服藥援助計(jì)劃，取得卓然成效，也積累了防控疫情的豐富技術(shù)經(jīng)驗(yàn)。

  這次疫情發(fā)生以來(lái)，中國(guó)政府本著高度負(fù)責(zé)的態(tài)度，積極主動(dòng)開(kāi)展國(guó)際合作，第一時(shí)間向世界衛(wèi)生組織通報(bào)疫情以及分享有關(guān)技術(shù)信息，如毒株的全基因組序列等。在中國(guó)國(guó)家衛(wèi)生健康委員會(huì)官方網(wǎng)站上，每日更新匯總?cè)珖?guó)疫情變化數(shù)據(jù)，實(shí)時(shí)向全世界發(fā)布。在應(yīng)對(duì)疫情的科技攻關(guān)中，我們積極拓展與國(guó)際組織和相關(guān)國(guó)家的科技合作。例如廣東省已與美國(guó)、加拿大、德國(guó)、以色列等國(guó)家的科學(xué)家開(kāi)展了疫情相關(guān)聯(lián)合研究，同時(shí)歡迎更多外國(guó)專家來(lái)粵合作，并提供專門防疫住宿保障。廣東抗擊疫情的領(lǐng)軍專家鐘南山院士和我本人于1月30日在廣州分別會(huì)見(jiàn)了世界著名“病毒獵手”美國(guó)哥倫比亞大學(xué)感染與免疫研究中心的利普金教授，就廣東疫情應(yīng)對(duì)情況與其進(jìn)行了交流，支持其與本地機(jī)構(gòu)開(kāi)展在流行病防控領(lǐng)域的科研合作。

  病毒沒(méi)有國(guó)界，疫情是全人類共同面對(duì)的挑戰(zhàn)。中國(guó)發(fā)生疫情以來(lái)，多個(gè)國(guó)家對(duì)中國(guó)進(jìn)行了醫(yī)療物資援助，開(kāi)展抗疫科研合作。對(duì)于這些善意，我們深表感謝。我還關(guān)注到，歐盟、相關(guān)國(guó)際組織及有關(guān)國(guó)家就新型冠狀病毒已發(fā)布開(kāi)展國(guó)際聯(lián)合研究的項(xiàng)目招標(biāo)。我們相信，通過(guò)國(guó)際社會(huì)的共同努力，我們一定能在不久的將來(lái)打贏這場(chǎng)疫情防控阻擊戰(zhàn)?！盎茧y見(jiàn)真情”，經(jīng)歷風(fēng)雨，我們的友誼必將歷久彌堅(jiān)，我們的合作將更加牢固。

  誠(chéng)懇希望您繼續(xù)關(guān)注和支持我們。疫情過(guò)后，中國(guó)將依然是那個(gè)充滿活力的安全國(guó)度，歡迎您來(lái)參加國(guó)際會(huì)議、工作、生活、交流，我們期盼著與您重逢在春暖花開(kāi)之時(shí)。

  祝您在新的一年里幸福安康！

  聯(lián)合國(guó)科技促進(jìn)發(fā)展委員會(huì)（UNCSTD）第22屆副主席/廣東省科學(xué)技術(shù)廳廳長(zhǎng) 王瑞軍博士

  2020年2月19日

A Letter to Foreign Experts and Friends

Dear Foreign Experts, Friends,

In this new year, the whole nation of China and the world are concerned with the outbreak of the novel coronavirus epidemic. I would like to extend my heartfelt gratitude for your concern and support for this epidemic control and prevention in China.

After the outbreak, the Chinese government immediately set up a nationwide mechanism to mobilize resources from across the country. We have taken the most comprehensive, stringent and thorough prevention and control measures, many of which are well beyond what is required by the International Health Regulations and the recommendations of World Health Organization (WHO). President Xi Jinping has made important instructions several times on the epidemic control and prevention. He has chaired central government meetings and listened to work reports to study the situation, to deploy solutions and to mobilize the state for this work of top priority. The whole country adopts a joint prevention and control mechanism headed by the state council. Under this mechanism, All possible measures are taken to fully receive and guarantee the medical treatment of critical patients infected with COVID-19 in hospitals. Every effort is made to take necessary quarantine measures and provide medical support for all suspected cases and close contacts.  Based on the real time monitoring of case data and experts’ predication, the epidemic tends to be effectively under control. For example, outside Hubei province, the daily adding number of confirmed cases has been declining for 15 consecutive days across China with a cumulative drop of over 70%; there is a rapid increase in the cure rate and over 10,000 people have recovered and been discharged from hospital.

Vast group of scientific and technological practitioners in China are intensively engaged in research to tackle the problems in epidemic curb and medical treatment. The governmental scientific and technological organs have launched several emergency-tackling research programs on the novel coronavirus disease prevention and control in related areas including key technologies for clinical treatment of severe pneumonia case of COVID-19, comprehensive research on hospital infection prevention and control, traceability and epidemiological studies, pathogenesis research, development and production of vaccine, and drug research and development, etc. At present, some research achievements have been made in clinical drug, rapid-test kits, virus pathogenesis and transmission channels, which provide technical support for fight against the epidemic. For example, in Guangdong province where I live and work, we are committed to the development of new anti-epidemic drugs and new use of old drugs in the way of integration of traditional Chinese and Western medicine and international cooperative research. We have successfully selected some Chinese and Western medicines with clinical effect. A local research team has developed a 15-minute rapid diagnostic kit, which has finished the preliminarily evaluation in laboratory and in clinical use. New type of isolation bed and isolation diagnosis platform have been developed and used in local designated hospitals to improve the level of nosocomial infection prevention and control. Vaccine research and development is expected to make stage progress in the near future, and research on epidemic traceability is making progress. The Recombinant SARS-CoV-2 virus N protein has been successfully synthesized inGuangdong Laboratory Animal Monitoring Institute, and is shared for free with the whole world to shorten the related research with less R&D expenditure, and to guide the establishment of correct scientific research value orientation. So far, more than 1090 strain samples have been given out to domestic and international research teams. Moreover, robot, AI, big data, UAV and other technologies are widely used to support epidemic prevention and control. Guangdong has taken law-based, scientific, robust and effective measures in curbing the epidemic. As such, the society is stable with sufficient supply of daily necessities, functional public transportation, and smooth transportation for medical, essential and epidemic control related supplies. The province is welcoming the flow of migrant workers to return to work and is supporting enterprises to resume production in a classified and orderly manner. I would also like to share the following facts of Guangdong with you. Since the victory of our battle against SARS in 2003, Guangdong has been focusing on its capacity building in R&D of epidemic management. The prevention and control mechanism being constantly improving. In recent years, it has successfully identified and blocked local spread of H1N1, MERS and other viruses that became epidemic in other countries. So far, no more scale epidemics happen in the province again.

The Chinese government and people have always showed empathy for the epidemic outbreaks in other countries and regions by providing humanitarian assistance as well as helping to develop vaccines, clinical diagnosis and drugs. For example, we have successfully developed influenza A (H1N1) vaccine. In cooperation with other countries, we have accomplished the development of fully humanized monoclonal antibody (m336), which becomes one of the best therapeutic drugs for MERS. We have also developed anti-malaria drugs and funded the mass drug administration programs in countries such as Comoros and Papua New Guinea where people suffered from malaria. Remarkable results have been achieved and related experiences have been accumulated.

As a responsible country, the Chinese government has from the start acted in an open and transparent manner in releasing relevant information and seeking international cooperation to prevent the spread of the epidemic worldwide. We have shared with WHO relevant technical information such as the whole genome sequence of the virus strain at a very early time. On the official website of the National Health Commission of China, real time data of national epidemic changes are updated daily to the whole world. At the same time, we actively expand scientific and technological cooperation with international organizations and other countries in response to the epidemic.For example, joint research with scientists from the United States, Canada, Germany, Israel and other countries in epidemic related research are progressing in Guangdong. More foreign experts are welcome to the province for joint research and special accommodation for epidemic prevention will be provided. On January 30th in Guangzhou,renowned Chinese respiratory expert Nanshan Zhong and I met with the world-famous Virus Hunter, Professor Walter Ian Lipkin from the Center for Infection and Immunity at Columbia’s Mailman School of Public Health respectively. We exchanged with him the response to the epidemic in Guangdong and I supported him to carry out scientific research cooperation with local institutions in the field of epidemic prevention and control.

Virus respects no borders. Epidemic caused by viral infectious disease represents a challenge for all mankind. Since the outbreak of this epidemic in China, many countries have provided medical material assistance to us and developed international joint research projects for epidemic containing. We are truly grateful for these acts of kindness. I also notice that calls for international joint research projects on related studies of novel coronavirus epidemic have been issued by the European Union, some international organizations and other countries. We believe that, with the joint efforts of international community, we will surely win this battle against the epidemic in the near future. Adversity reveals true friendship. Emerging from this test, our friendship will be strengthened and our cooperation will become even firmer.

Your sustaining concern and support will be much appreciated. After the epidemic , that dynamic and secure country will   come back again. Welcome you to return for international meetings, for work, for stay and for further exchanges. We are looking forward to meeting you again in the spring blossoms.

I wish you happiness and health in the New Year!

Dr. Ruijun Wang

Director General of Department of Science and Technology of Guangdong Province, P.R.C

Vice-Chairman of the 22nd Session, UNCSTD

19th February, 2020

來(lái)源：省科技廳網(wǎng)站